1
|
Jung V, Krösser S, Burian G, Grillenberger R, Korward J, Roesky C. Further contribution to the discussion on perfluorohexyloctane eye drops in dry eye disease. Sci Total Environ 2024; 906:168040. [PMID: 37879467 DOI: 10.1016/j.scitotenv.2023.168040] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/11/2023] [Revised: 10/09/2023] [Accepted: 10/20/2023] [Indexed: 10/27/2023]
Affiliation(s)
- Verena Jung
- Novaliq GmbH Heidelberg, Im Neuenheimer Feld 515, 79120 Heidelberg, Germany.
| | - Sonja Krösser
- Novaliq GmbH Heidelberg, Im Neuenheimer Feld 515, 79120 Heidelberg, Germany
| | - Gabriela Burian
- Novaliq GmbH Heidelberg, Im Neuenheimer Feld 515, 79120 Heidelberg, Germany
| | - Ralf Grillenberger
- Novaliq GmbH Heidelberg, Im Neuenheimer Feld 515, 79120 Heidelberg, Germany
| | - Johannes Korward
- Novaliq GmbH Heidelberg, Im Neuenheimer Feld 515, 79120 Heidelberg, Germany
| | - Christian Roesky
- Novaliq GmbH Heidelberg, Im Neuenheimer Feld 515, 79120 Heidelberg, Germany
| |
Collapse
|
2
|
Fischer K, Grillenberger R, Amar T, Krösser S. Exploratory ocular surface distribution studies of Azithromycin formulations based on semifluorinated alkanes. Acta Ophthalmol 2017. [DOI: 10.1111/j.1755-3768.2017.0s029] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- K. Fischer
- Preclinical & Clinical Development; Novaliq GmbH; Heidelberg Germany
| | | | - T. Amar
- Preclinical Development; Iris Pharma; La Gaude France
| | - S. Krösser
- Preclinical & Clinical Development; Novaliq GmbH; Heidelberg Germany
| |
Collapse
|